Login / Signup

Optimal Biologic Drugs for the Treatment of Ankylosing Spondylitis: Results from a Network Meta-Analysis and Network Metaregression.

Ziqin CaoJia GuoQiangxiang LiYajia LiJian-Huang Wu
Published in: BioMed research international (2022)
inhibitors, especially infliximab, are safe and effective and could be a first-line treatment choice.
Keyphrases
  • ankylosing spondylitis
  • rheumatoid arthritis
  • disease activity
  • systemic lupus erythematosus
  • ulcerative colitis
  • decision making